MOLBIO DIAGNOSTICS LTD Share Price

₹ 1,350.80

+₹36.70 (2.79%)
1D
Last updated 03 Nov, 2026, 15:56 IST
NSE: MOLBIO
|
Healthcare

MOLBIO DIAGNOSTICS LTD Share Price Today

As of 4 Nov 2026, MOLBIO DIAGNOSTICS LTD share price is ₹1,350.80. The stock opened at ₹1,326.00, compared to its previous close of ₹1,314.10. During today's trading session, MOLBIO DIAGNOSTICS LTD share price moved in the range of ₹1,305.00 to ₹1,364.40, with an average price of ₹1,334.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹926.35 and a high of ₹1,686.80.

Share price over the last 1 day rose from 1317.50 to 1349.80, ranging between 1306.60 and 1363.20.
₹1,305.00
2.79% up today
₹1,364.40
1D LOW
1D HIGH

MOLBIO DIAGNOSTICS LTD Stock Insights

Latest Earning
Op Profit TrendUp by 18.88% YoY
Latest Earning
Net Profit TrendUp by 18.44% YoY
Latest Earning
Revenue TrendUp by 41.56% YoY
Stock Performance
OutperformingBeat Nifty by 30.92 % in last 3 month
Shareholding Pattern
DIIDII decreased stake by 21.72%
Shareholding Pattern
FIIFII increased stake by 5.28%
MOLBIO DIAGNOSTICS LTD stock performance
Open₹1,326.00
High₹1,364.40
Low₹1,305.00
Prev. close₹1,314.10
MOLBIO DIAGNOSTICS LTD trading activity
Volume5,96,682
Average traded price₹1,344.72
Last traded time03:56:23 03 Nov
Last traded quantity20
Circuit
L
H
₹1,080.70
₹1,620.90
52-week
L
H
₹926.35
₹1,686.80
Mkt Cap Cr
15,125.83
P/E
104.59
P/B
11.33
ROA
9.42%
ROE
15.36%
ROCE
19.08%
Quick Ratio
1.68
EV/EBITDA
0.0

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Molbio Diagnosti has not beaten FD return of 7%
Valuation: 3 out of 5, Fairly Valued
Valuation
Fairly Valued
Molbio Diagnosti appears to be fairly valued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Molbio Diagnosti earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Apollo Hospitals1,21,066.6855.7412.779.79%20.48%17.27%0.9830.42
Max Healthcare87,015.4462.287.597.37%12.18%13.24%0.8433.68
Manipal Health Enterprises Limited84,795.7993.565.164.07%10.59%9.51%1.1733.95
Aster DM Healthcare58,742.01162.013.964.47%8.48%10.1%1.966.59
Fortis Healthcare57,376.8255.325.996.7%10.53%12.56%0.827.8
Narayana Hrudayalaya35,143.9343.77.56.43%17.17%12.26%2.0719.68
Global Health34,121.9064.599.08.36%14.05%15.26%2.5433.04
Dr. Lal Path Labs31,681.4657.9912.6317.36%20.13%25.56%3.3834.28
KRISHNA INST OF MED SCI L30,681.47157.788.192.51%10.74%7.99%0.6840.03
Syngene International16,251.7289.533.432.79%5.47%7.06%1.2922.34

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

MOLBIO DIAGNOSTICS LTD Company Background

ISIN
INE869T01028
Sector Market Cap
₹ 15,125.83 Cr

MOLBIO DIAGNOSTICS LTD Financial Highlights

  • Revenue: MOLBIO DIAGNOSTICS LTD reported revenue of ₹1,455.17 crore in FY26 vs ₹1,027.94 crore in FY25. It showed an increase of 41.56% on a yearly basis.
  • Operating Profit: MOLBIO DIAGNOSTICS LTD reported an operating profit of ₹231.14 crore in FY26 vs ₹194.43 crore in FY25. It showed an increase of 18.88% on a year-on-year basis.
  • Net Profit: MOLBIO DIAGNOSTICS LTD reported a net profit of ₹164.14 crore in FY26 vs ₹138.58 crore in FY25. It showed an increase of 18.44% on a yearly basis.

MOLBIO DIAGNOSTICS LTD Quarterly Result Highlights

  • MOLBIO DIAGNOSTICS LTD reported revenue of ₹411.48 crore in Jun 2026, compared with ₹565.41 crore in Mar 2026, representing a decrease of 27.22% on a quarter-on-quarter (QoQ) basis.
  • MOLBIO DIAGNOSTICS LTD reported an operating profit of ₹75.91 crore in Jun 2026, compared with ₹131.83 crore in Mar 2026, representing a decrease of 42.42% on a quarter-on-quarter (QoQ) basis.
  • MOLBIO DIAGNOSTICS LTD reported a profit of ₹52.74 crore in Jun 2026, compared with ₹95.83 crore in Mar 2026, reflecting a decrease of 44.97% on a QoQ basis.
  • The earnings per share (EPS) of MOLBIO DIAGNOSTICS LTD stood at ₹14.77 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
41.29%
FII
1.59%
Other DII
11.06%
Retail and other
38.03%
Mutual funds
8.03%
Foreign Institutional Investor (FII)
FII shareholding by period
Aug 20250.00%
Aug 20261.51%
Sep 20261.59%

MOLBIO DIAGNOSTICS LTD Investment Returns

1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--

MOLBIO DIAGNOSTICS LTD Share Price History

MOLBIO DIAGNOSTICS LTD share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
03 Nov 26
₹1,326.00 / ₹1,350.80
+2.79%
02 Nov 26
₹1,278.80 / ₹1,314.10
+3.15%
30 Oct 26
₹1,315.00 / ₹1,274.00
-2.20%
29 Oct 26
₹1,320.40 / ₹1,302.60
-0.77%
Show more

MOLBIO DIAGNOSTICS LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,445.69₹1,020.42₹836.56₹332.46
Other Income₹9.48₹7.52₹4.10₹4.95
Total Revenue₹1,455.17₹1,027.94₹840.66₹337.41
Total Expenses₹1,221.35₹820.41₹657.83₹327.87
Profit Before Tax₹231.14₹194.43₹129.64₹9.54
Tax₹67.00₹55.85₹46.10₹12.99
Profit After Tax₹164.14₹138.58₹83.54-₹3.45
EPS - Basic₹14.77₹12.87₹9.05-₹0.06
EPS - Diluted₹14.77₹12.87₹9.04-₹0.06

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹231.14₹194.43₹129.64₹9.54
Income before WC changes₹352.83₹285.11₹273.13₹47.06
Change in Assets-₹256.81-₹54.68-₹252.20₹19.86
Change in Liabilities₹25.05₹136.54₹32.10₹35.36
Change in WC-₹231.76₹81.86-₹220.10₹55.22
Cash flow from Operations₹50.39₹287.10₹9.57₹64.13
Cash flow from Investing-₹93.22-₹122.65-₹45.01-₹39.73
Cash flow from Financing₹276.07-₹26.15-₹31.55₹18.24
Total Cash Flow₹233.23₹138.30-₹66.99₹42.64
Cash (Start of the year)₹63.23-₹75.07-₹8.08-₹50.72
Cash (End of the year)₹335.77₹63.23-₹75.07-₹8.08

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹763.58₹531.72₹397.90₹422.79
Current Assets₹1,384.84₹929.83₹823.16₹611.42
Total Assets₹2,148.42₹1,461.56₹1,221.06₹1,034.21
Current Liabilities₹557.36₹441.67₹342.76₹257.55
Net Current Asset₹827.48₹488.17₹480.40₹353.88
Non-Current Liabilities₹282.29₹52.61₹49.46₹39.32
Equity Capital₹1,308.78₹967.29₹828.84₹737.34
Total Equity & Liabilities₹2,148.42₹1,461.56₹1,221.06₹1,034.21

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,313.40₹971.23₹756.32₹326.57
Other Income₹7.72₹6.37₹6.52₹8.10
Total Revenue₹1,321.11₹977.60₹762.84₹334.67
Total Expenses₹1,120.43₹780.77₹583.83₹311.82
Profit Before Tax₹197.55₹188.04₹151.89₹22.86
Tax₹52.92₹48.22₹40.78₹7.31
Profit After Tax₹144.63₹139.82₹111.11₹15.55
EPS - Basic₹12.83₹12.40₹9.86₹6.91
EPS - Diluted₹12.83₹12.40₹9.85₹6.90

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹197.55₹188.04₹151.89₹22.86
Income before WC changes₹276.39₹246.80₹237.51₹42.40
Change in Assets-₹226.61-₹64.87-₹190.96₹58.28
Change in Liabilities-₹34.47₹131.22₹33.88₹0.00
Change in WC-₹261.09₹66.35-₹157.07₹58.28
Cash flow from Operations-₹37.98₹248.58₹37.74₹67.90
Cash flow from Investing-₹256.25-₹97.90-₹31.44-₹51.01
Cash flow from Financing₹292.39-₹17.35-₹24.20₹30.96
Total Cash Flow-₹1.84₹133.33-₹17.91₹47.84
Cash (Start of the year)₹110.77-₹22.56-₹4.65-₹52.49
Cash (End of the year)₹108.93₹110.77-₹22.56-₹4.65

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹737.10₹480.94₹353.68₹308.78
Current Assets₹1,003.54₹826.53₹723.52₹610.76
Total Assets₹1,740.63₹1,307.47₹1,077.20₹919.54
Current Liabilities₹381.53₹303.94₹209.81₹177.60
Net Current Asset₹622.01₹522.59₹513.71₹433.16
Non-Current Liabilities₹224.39₹13.46₹17.41₹2.97
Equity Capital₹1,134.71₹990.07₹849.98₹738.97
Total Equity & Liabilities₹1,740.63₹1,307.47₹1,077.20₹919.54
* All values are in INR Crore
MOLBIO DIAGNOSTICS LTD market depth
Bid quantityBid priceAsk priceAsk quantity
001350.895
0000
0000
0000
0000
Total bid quantity0
Total ask quantity95
MOLBIO DIAGNOSTICS LTD technical summary
Bearish indicators1
Neutral indicators5
Bullish indicators2
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
49.79
Neutral
ATR (14)
95.91
Neutral
STOCH(9,6)
35.92
Neutral
STOCH RSI (14)
24.01
Neutral
ADX(9)
16.79
Bullish
UO(9)
42.31
Neutral
ROC(12)
-10.07
Bearish
WillR(14)
-80.77
Bullish
Period
Simple value
Exponential vaue
5D
1293.84
1299.37
10D
1299.89
1317.31
20D
1392.24
1342.88
50D
1294.36
1301.97
100D
1281.27
0
Volume trend — traded volume by day
3 Nov5L
2 Nov6L
30 Oct5L
29 Oct2L
28 Oct7L
Average5L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

MOLBIO DIAGNOSTICS LTD
Healthcare
Add Stock
Add Another

MOLBIO DIAGNOSTICS LTD Returns Calculator

MOLBIO DIAGNOSTICS LTD Latest News

1 month ago
MTNL, Kotak Bank, Sterlite Tech among buzzing stocks as SENSEX, NIFTY50 tumble over 1% in noon deals
1 month ago
Molbio Diagnostics shares surge 35% in two sessions; here’s why the healthcare stock hit record high on Sept 10
Showing news item 1 of 2

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

MOLBIO DIAGNOSTICS LTD Share Price FAQs

Please be aware that MOLBIO DIAGNOSTICS LTD stock prices are subject to continuous fluctuations due to various factors.